IGHG1 and neoplasm: In intrahepatic cholangiocarcinoma (ICC), JCHAIN is a core marker of the “plasma cell+” immune infiltration pattern (co-expressed with IGHG1), which correlates with favorable overall survival by enhancing anti-tumor immunity.